Figure 1
From: CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness
(A) Stable overexpression of CEACAM6 was confirmed in two Capan2-derived transfectants, pIRES-CEACAM6.1 and pIRES-CEACAM6.2, by Western blotting. Representative example with mean densitometric values (±s.d.) from triplicate blots. *P<0.05 vs pIRES (empty vector) transfectants. (B) Cellular invasiveness in the Matrigel Boyden chamber assay was significantly increased in both pIRES-CEACAM6.1 and pIRES-CEACAM6.2 transfectants. Values are means (±s.d.) from triplicate experiments. *P<0.05 vs pIRES transfectants.
